First IBC Social Impact Awards Celebrate Industry Diversity, Sustainability & Ethical Leadership
The industry’s sense of social responsibility is stronger than ever, movements championing diversity and inclusivity are gathering momentum at an unprecedented pace and there is a conscious increase in company initiatives making a positive impact in the wider world. To reflect this, and its commitment to driving change in the industry, IBC is for the first time recognising social responsibility as part of its prestigious awards programme with a stand-alone award – the Social Impact Award.
This year’s call for entries received an overwhelming response and with so many impressive and impactful projects submitted the judges were moved to create three shortlists, recognising initiatives focused on diversity and inclusivity, on minimising environmental impact, and for the best ethical leadership. One winner from each category will be announced at the IBC Awards Ceremony.
“The decision facing us as judges was tremendously hard. The quality of the entries was exceptionally high, and all the initiatives submitted have real purpose,” said Ade Rawcliffe, Head of Diversity for ITV Commissioning and Chair of the Social Impact Award Judging Panel. “This reflects what’s going on in the industry worldwide,” she added. “There is a real shift, a positive drive to not just create and deliver great content, but to do it with the best people from the widest range of backgrounds, with real audience engagement, and with the smallest possible environmental footprint.”
Recognising everything from projects making the industry more inclusive, both by ensuring clear career paths for women and in engagement with the young and the disadvantaged, to a focus on societal issues from drink driving to recycling, this year’s shortlist demonstrates the breadth of projects in the industry working to improve the world around us.
Shortlisted in the Diversity and Inclusivity category are:
- Flex, A BBC cultural transformation to introduce a new flexible working policy, supporting career progression for women and men. As of July 2019, 80% of BBC vacancies have been advertised with flexible working, both in the UK and globally
- Broadcast Academy, which provides a practical environment to develop technical and operational skills, with a particular emphasis on creating a diverse and multicultural talent pool and increasing the number of women in sports broadcasting. Broadcast Academy is part of HBS, a company that specialises in the host broadcasting of sports events
- Journalism for Juniors, an initiative from Turkish broadcaster TRT which teaches disadvantaged young people and refugee children – in Turkey and overseas – how to tell their stories through the medium of journalism, not just to encourage them to make it their career but to understand the importance of trusted information
There are two finalists in the Environmental Impact category:
- VoxA Omnichannel Engagement Platform, an advanced and extensive emergency alert and advisory platform for half a billion Indians living in India’s coastal communities, developed by Gaian Solutions for the Government of India, Ministry of Earth Sciences
- Liquid Technology, a leader in the recycling of electronic equipment, eliminating the risk of harmful materials like cadmium, lead and rare earth metals finding their way into landfill
The third category for Ethical Leadership has three finalists:
- An immersive, virtual reality experience to put you in the shoes of a drunk driver and experience its agonising consequences – created by BBDO DUBLIN and Inition for the Irish Road Safety Authority (RSA)
- Combining green filmmaking and creative flair Chouette Films, an associate member of SOAS, University of London, crafts films with the ingredients to inspire social impact with the smallest possible environmental footprint
- The gunman in the Christchurch massacre was welcomed into the Al Noor Mosque with the words “hello brother” – TRT created an online video campaign for citizens worldwide to share their stories under the hashtag #hellobrother
Who will take home the – newly redesigned, from sustainable materials – trophies? The winners will be revealed at the IBC2019 Awards Ceremony at 18:30 on Sunday 15 September. Your ticket to the IBC Awards Ceremony is included in your free IBC exhibition visitor pass. Register now: show.ibc.org/register .
## ENDS ##
Notes to Editors:
IBC is the world’s most influential media, entertainment and technology show, attracting 55,000+ attendees from more than 170 countries and combining a highly respected and peer-reviewed conference with an exhibition that showcases 1,700+ leading industry suppliers of state-of-the-art technology. In addition to the world-class exhibition and conference, IBC also encompasses the IBC Daily, IBCTV and IBC365.
IBC365 provides year-round insight and opinion into the hot topics and key trends from leading industry journalists, along with insightful whitepapers, peer reviewed technical papers, highly engaging webinars and an expansive video library.
Conference: 13 - 17 September 2019
Exhibition: 13 - 17 September 2019
For more information about IBC2019 visit: show.ibc.org
Amy Swallow, Bubble Agency
T: +44 7872 831167
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 17:59:00 CEST | Press release
Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who
Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 13:05:00 CEST | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 12:30:00 CEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include
Schlumberger Announces Second-Quarter 2019 Results19.7.2019 11:00:00 CEST | Press release
Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente
Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 10:46:00 CEST | Press release
Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe
Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 10:00:00 CEST | Press release
Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail firstname.lastname@example.org or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu